APLN and cancer: KEGG enrichment analysis showed that RP11-89K21.1 targeted genes were significantly enriched in pathways in cancer, endocrine resistance and microRNAs in cancer, regulated apelin signaling pathway, Th17 cell differentiation and hippo signaling pathway (Fig. 7g, h, Table 5).